AI주식인사이트AI Stock Insight
C

제노레이

122310KOSDAQ의료용 기기 제조업

52.3 / 100

Reference Date: 2026-07-24

Financial Score13.5 / 40
News Sentiment19.8 / 25
Momentum7.0 / 20
Disclosure12.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but PER raises overvaluation concerns. Rose 5.1% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Genoray develops, manufactures, and sells X-ray imaging diagnostic equipment for medical and dental environments. The company operates both medical (C-arm, Mammography) and dental (Panorama, CT, Portable) segments, uniquely being the only South Korean firm offering both. The medical segment focuses on real-time imaging during surgeries and breast disease diagnosis, while the dental segment provides high-resolution 3D imaging technology for dental treatments and implant surgery.

Number of Employees

358people

Average Salary

56.6M KRW

Score Calculation Basis

Detailed Financial Score

PER
57.70Industry Average 20.040.0Point

2.9x industry avg (risky)

PBR
0.61Industry Average 1.145.5Point

Lower than industry avg (good)

ROE
0.74Industry Average 8.001.0Point

Well below industry avg

Debt Ratio
8.99Industry Average 11.654.0Point

In line with industry avg

Trend 2023~20253.0 / 10 points
Revenue Growth Rate
2.0 / 3

Avg ▲5.1% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼76.4% (2-year basis)

ROE Trend
1.0 / 4

Avg ROE 3.8% (declining, 3yr)

Detailed News Sentiment

8 totalPositive 7Neutral 1Negative 0Average Sentiment Score 79.4

Detailed Momentum

52-week position1.0Point

Near 52w low (12%, downtrend)

Current 3,520Won52-week high 5,77052-week low 3,200
1-month return4.0Point

1m +5.07% (slight rise)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

4 totalPositive 1Neutral 3Negative 0
  • Neutral주식등의대량보유상황보고서(일반)2026-07-21
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-01
  • Positive현금ㆍ현물배당결정 (분기배당)2026-07-01
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-29